BridgeMD
Compares treatment options for Preterm Birth Complication
Official title Delayed Versus Immediate Cord Clamping in Preterm Birth
ClinicalTrials.gov ID: NCT07699666
What this study is testing
- What it's testing
- The goal of this study is to evaluate whether delayed cord clamping improves early neonatal outcomes compared with immediate clamping in preterm birth. Preterm infants are at higher risk of neonatal complications, and the timing of cord clamping may influence placental transfusion and neonatal adaptation after birth.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 and older
You may be able to join if
- Preterm neonates born at gestational age between 32 and 37 weeks
- Live-born infants delivered in the study center
- Singleton pregnancies
- Parental consent obtained when applicable according to institutional ethical requirements
You likely can't join if
- Major congenital malformations or chromosomal abnormalities
- Need for immediate advanced resuscitation at birth
- Severe fetal distress requiring emergency obstetric intervention incompatible with protocol allocation
- Placental conditions contraindicating delayed cord clamping (e.g., placental abruption with maternal instability, placenta previa bleeding, Placenta...
- Intra Uterin Growth Restriction with abnormal umbilical artery Doppler velocimetry
The study team makes the final eligibility decision.
Where it's taking place
- Tunis, Tunis Governorate, Tunisia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tunis, Tunis Governorate, Tunisia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.